COMPASS PATHWAYS PLC Shares Outstanding
COMPASS PATHWAYS PLC (CMPS) had Shares Outstanding of 135.72 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-05
- 2026-06-30: Shares outstanding (split-adjusted) 135.72M shares; Shares authorized (split-adjusted) 135.72M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 134.92M shares; Shares authorized (split-adjusted) 134.92M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 96.09M shares; Shares authorized (split-adjusted) 96.09M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 96.00M shares; Shares authorized (split-adjusted) 96.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 135.72M shares 10-Q · filed 2026-08-05 | 135.72M shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 134.92M shares 10-Q · filed 2026-05-13 | 134.92M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 96.09M shares 10-Q · filed 2026-08-05 | 96.09M shares 10-Q · filed 2026-08-05 |
| 2025-09-30 | 96.00M shares 10-Q · filed 2025-11-04 | 96.00M shares 10-Q · filed 2025-11-04 |
| 2025-06-30 | 93.59M shares 10-Q · filed 2025-07-31 | 93.59M shares 10-Q · filed 2025-07-31 |
| 2025-03-31 | 92.85M shares 10-Q · filed 2025-05-08 | 92.85M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 68.55M shares 10-K · filed 2026-03-24 | 68.55M shares 10-K · filed 2026-03-24 |
| 2024-09-30 | 68.41M shares 10-Q · filed 2024-10-31 | 68.41M shares 10-Q · filed 2024-10-31 |
| 2024-06-30 | 68.39M shares 10-Q · filed 2024-08-01 | 68.39M shares 10-Q · filed 2024-08-01 |
| 2024-03-31 | 68.34M shares 10-Q · filed 2024-05-08 | 68.34M shares 10-Q · filed 2024-05-08 |
| 2023-12-31 | 61.94M shares 10-K · filed 2025-02-27 | 61.94M shares 10-K · filed 2025-02-27 |
| 2021-06-30 | 41.70M shares 6-K · filed 2021-08-11 | (m) |
| 2020-12-31 | 35.93M shares 6-K · filed 2021-11-09 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |